Bolt Biotherapeutics, Inc.
BOLT$4.74▲ 2.38% 24h
$4.74
+$1.77(+59.71%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$9.11M
P/E ratio
—
EPS (diluted)
$-17.85
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$7.70M
Net income
$-33.38M
Net margin
-433.7%
Gross margin
—
Dividends & financials
Bolt Biotherapeutics, Inc. (BOLT) reported revenue of $7.70M and net income of $-33.38M, or $-17.85 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
